Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug cand...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:iScience
Main Authors: Ohashi, Hirofumi, Watashi, Koichi, Saso, Wakana, Shionoya, Kaho, Iwanami, Shoya, Hirokawa, Takatsugu, Shirai, Tsuyoshi, Kanaya, Shigehiko, Ito, Yusuke, Kim, Kwang Su, Nomura, Takao, Suzuki, Tateki, Nishioka, Kazane, Ando, Shuji, Ejima, Keisuke, Koizumi, Yoshiki, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Suzuki, Tadaki, Hashiguchi, Takao, Maenaka, Katsumi, Matano, Tetsuro, Muramatsu, Masamichi, Saijo, Masayuki, Aihara, Kazuyuki, Iwami, Shingo, Takeda, Makoto, McKeating, Jane A., Wakita, Takaji
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2021
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7997640/
https://ncbi.nlm.nih.gov/pubmed/33817567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2021.102367
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים